Correlation Between Cardiff Oncology and Coya Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cardiff Oncology and Coya Therapeutics, Common, you can compare the effects of market volatilities on Cardiff Oncology and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and Coya Therapeutics,.

Diversification Opportunities for Cardiff Oncology and Coya Therapeutics,

0.36

Correlation Coefficient

Cardiff Oncology  Coya Therapeutics,

Weak diversification

The 3 months correlation between Cardiff and Coya is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and Coya Therapeutics, go up and down completely randomly.

Pair Corralation between Cardiff Oncology and Coya Therapeutics,

Given the investment horizon of 90 days Cardiff Oncology is expected to generate 1.36 times more return on investment than Coya Therapeutics,. However, Cardiff Oncology is 1.36 times more volatile than Coya Therapeutics, Common. It trades about 0.05 of its potential returns per unit of risk. Coya Therapeutics, Common is currently generating about 0.05 per unit of risk. If you would invest  151.00  in Cardiff Oncology on September 10, 2024 and sell it today you would earn a total of  80.00  from holding Cardiff Oncology or generate 52.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Cardiff Oncology  vs.  Coya Therapeutics, Common

Cardiff Oncology

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cardiff Oncology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental indicators, Cardiff Oncology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Coya Therapeutics, Common

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Coya Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Coya Therapeutics, sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cardiff Oncology and Coya Therapeutics,

The main advantage of trading using opposite Cardiff Oncology and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.

The idea behind Cardiff Oncology and Coya Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.